| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.5 |
| mRNA | NU-7441 | GDSC1000 | pan-cancer | AAC | 0.028 | 0.6 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | 0.027 | 0.6 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.031 | 0.6 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | 0.025 | 0.6 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.6 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.6 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.049 | 0.6 |
| mRNA | BIRB 0796 | FIMM | pan-cancer | AAC | 0.11 | 0.6 |